{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:32:28Z","timestamp":1767907948932,"version":"3.49.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.clinthera.2018.04.016","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T01:37:46Z","timestamp":1527125866000},"page":"1034-1045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti\u2013TNF-\u03b1 Agents on B Lymphocytes: A Review of the Literature"],"prefix":"10.1016","volume":"40","author":[{"given":"Ozlem","family":"Pala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie B.","family":"Blomberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.04.016_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2018.04.016_bib2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.04.016_bib3","first-page":"673","article-title":"Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature","volume":"26","author":"Levy","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib4","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.10529","article-title":"Predictors of infection in rheumatoid arthritis","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib5","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"Galloway","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2018.04.016_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/keg263","article-title":"Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy","volume":"42","author":"Kroesen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2018.04.016_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3816\/CLM.2008.n.009","article-title":"Incidence of lymphoma in patients with rheumatoid arthritis: a systematic review of the literature","volume":"8","author":"Kaiser","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.clinthera.2018.04.016_bib9","first-page":"1704","article-title":"Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans","volume":"35","author":"Khurana","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib10","first-page":"2130","article-title":"Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors","volume":"32","author":"Chakravarty","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2018.04.016_bib12","first-page":"14","article-title":"The role of B cells in the pathogenesis of rheumatoid arthritis","volume":"73","author":"Kotzin","year":"2005","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.clinthera.2018.04.016_bib13","first-page":"791","article-title":"Histopathology and molecular pathology of synovial B-lymphocytes in rheumatoid arthritis","volume":"15","author":"Krenn","year":"2000","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib14","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/art.22748","article-title":"Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis","volume":"56","author":"Timmer","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/ard.2008.089284","article-title":"Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis","volume":"68","author":"Canete","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2018.04.016_bib16","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.162.5.3053","article-title":"Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis","volume":"162","author":"Kim","year":"1999","journal-title":"J Immunology"},{"key":"10.1016\/j.clinthera.2018.04.016_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1073\/pnas.93.1.221","article-title":"Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis","volume":"93","author":"Schroder","year":"1996","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2018.04.016_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.2003.tb06042.x","article-title":"Ectopic germinal center formation in rheumatoid synovitis","volume":"987","author":"Weyand","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinthera.2018.04.016_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.coi.2012.04.003","article-title":"Chronic inflammation and aging: DNA damage tips the balance","volume":"24","author":"Cavanagh","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in early and late stages of rheumatoid arthritis","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/BOR.0000000000000011","article-title":"T-cell aging in rheumatoid arthritis","volume":"26","author":"Weyand","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib22","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.4049\/jimmunol.1700774","article-title":"Cutting edge: processing of oxidized peptides in macrophages regulates T cell activation and development of autoimmune arthritis","volume":"199","author":"Yang","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis","volume":"116","author":"Kuhn","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2018.04.016_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2017.06.004","article-title":"Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis","volume":"84","author":"Gronwall","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinthera.2018.04.016_bib25","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.174.6.3781","article-title":"Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis","volume":"174","author":"O'Neill","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib26","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.167.8.4710","article-title":"T cell activation in rheumatoid synovium is B cell dependent","volume":"167","author":"Takemura","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/annrheumdis-2013-204049","article-title":"B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis","volume":"74","author":"Rapetti","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2018.04.016_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/ard.44.8.549","article-title":"Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis","volume":"44","author":"Konttinen","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2018.04.016_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.autrev.2011.06.010","article-title":"B-cells and their targeting in rheumatoid arthritis\u2014current concepts and future perspectives","volume":"11","author":"Nakken","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinthera.2018.04.016_bib30","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/ar2823","article-title":"Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Nanki","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2018.04.016_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/BOR.0b013e3283369cb8","article-title":"B cells in the pathogenesis and treatment of rheumatoid arthritis","volume":"22","author":"Marston","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib32","doi-asserted-by":"crossref","first-page":"518S","DOI":"10.1042\/bst025518s","article-title":"NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation","volume":"25","author":"Gilston","year":"1997","journal-title":"Biochemical Society transactions"},{"key":"10.1016\/j.clinthera.2018.04.016_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/ar300","article-title":"NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction","volume":"3","author":"Makarov","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.clinthera.2018.04.016_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4(+) T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib35","first-page":"82","article-title":"Specific B lymphocytes efficiently pick up, process and present antigen to T cells","author":"Lanzavecchia","year":"1985","journal-title":"Behring Inst Mitt"},{"key":"10.1016\/j.clinthera.2018.04.016_bib36","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.164.12.6113","article-title":"Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses","volume":"164","author":"Hamano","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.189.2.371","article-title":"Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization","volume":"189","author":"Regnault","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinthera.2018.04.016_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2018.04.016_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.clinthera.2018.04.016_bib41","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3389\/fimmu.2017.01932","article-title":"MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis","volume":"8","author":"Alivernini","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib42","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1097\/MD.0000000000001326","article-title":"Role of Micro RNAs in the Pathogenesis of Rheumatoid Arthritis: Novel Perspectives Based on Review of the Literature","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinthera.2018.04.016_bib43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib44","doi-asserted-by":"crossref","first-page":"e0128269","DOI":"10.1371\/journal.pone.0128269","article-title":"Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of b cell depletion therapy, and biomarkers of response","volume":"10","author":"Adlowitz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2018.04.016_bib45","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.23498","article-title":"Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95","volume":"58","author":"Jacobi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib46","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinthera.2018.04.016_bib47","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J"},{"key":"10.1016\/j.clinthera.2018.04.016_bib48","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/eji.201546266","article-title":"Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes","volume":"46","author":"Kuzin","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10067-013-2359-3","article-title":"Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis","volume":"33","author":"Ma","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Science Translational Med"},{"key":"10.1016\/j.clinthera.2018.04.016_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13075-017-1244-x","article-title":"Th17 and CD24(hi)CD27(+) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis","volume":"19","author":"Salomon","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2018.04.016_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clim.2017.05.012","article-title":"Regulatory B cells in rheumatoid arthritis: alterations in patients receiving anti-TNF therapy","volume":"184","author":"Banko","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000082103","article-title":"B lymphocyte depletion in rheumatoid arthritis: targeting of CD20","volume":"8","author":"Edwards","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.clinthera.2018.04.016_bib54","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1073\/pnas.0709205105","article-title":"Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice","volume":"104","author":"Bouaziz","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2018.04.016_bib55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0962-8924(00)89088-1","article-title":"Two tumour necrosis factor receptors: structure and function","volume":"5","author":"Vandenabeele","year":"1995","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib56","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.158.8.3869","article-title":"Constitutive shedding of both p55 and p75 murine TNF receptors in vivo","volume":"158","author":"Pinckard","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib57","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2018.04.016_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.clinthera.2018.04.016_bib59","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-3083.1999.00458.x","article-title":"Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers","volume":"49","author":"Alsalameh","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/clim.2001.5027","article-title":"Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1","volume":"99","author":"Tada","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.clinthera.2018.04.016_bib62","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.167.6.3231","article-title":"Down-regulation of CD28 expression by TNF-alpha","volume":"167","author":"Bryl","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exger.2014.01.004","article-title":"High TNF-alpha levels in resting B cells negatively correlate with their response","volume":"54","author":"Frasca","year":"2014","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib64","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.4049\/jimmunol.0803449","article-title":"Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3","volume":"182","author":"Parish","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2018.04.016_bib66","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2018.04.016_bib67","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1073\/pnas.1011774108","article-title":"Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system","volume":"108","author":"Hess","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2018.04.016_bib68","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrrheum.2010.174","article-title":"Clinical trials: Tight control in early RA pays off in the long run","volume":"6","author":"Scott","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib69","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/art.22019","article-title":"Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis","volume":"54","author":"Roll","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib70","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.coi.2010.10.009","article-title":"Regulation of immunity and autoimmunity by B cells","volume":"22","author":"Mauri","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib71","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrrheum.2010.140","article-title":"Regulatory B cells in autoimmunity: developments and controversies","volume":"6","author":"Mauri","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cei.12335","article-title":"Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment","volume":"177","author":"Conigliaro","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib73","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar2718","article-title":"Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor","volume":"11","author":"Souto-Carneiro","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2018.04.016_bib74","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.180.2.688","article-title":"Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks","volume":"180","author":"Anolik","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/03009742.2011.645056","article-title":"RF positivity has substantial influence on the peripheral memory B-cell compartment and its modulation by TNF inhibition","volume":"41","author":"Roll","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib76","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/ar2985","article-title":"B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy","volume":"12","author":"Catalan","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2018.04.016_bib77","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar2570","article-title":"Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy","volume":"10","author":"Nicaise Roland","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2018.04.016_bib78","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.intimp.2017.11.016","article-title":"Anti-tumour necrosis factor-alpha antibodies and B cell homeostasis in human inflammatory bowel diseases","volume":"54","author":"Defendenti","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib79","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1097\/MIB.0000000000000554","article-title":"Anti-tumor necrosis factor therapy restores peripheral blood B-cell subsets and CD40 expression in inflammatory bowel diseases","volume":"21","author":"Li","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.clinthera.2018.04.016_bib80","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","article-title":"The incidence and management of infusion reactions to infliximab: a large center experience","volume":"98","author":"Cheifetz","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.clinthera.2018.04.016_bib81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.crohns.2013.01.009","article-title":"Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease","volume":"7","author":"Mocci","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10.1016\/j.clinthera.2018.04.016_bib82","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2012.10.021","article-title":"Immunogenicity and autoimmunity during anti-TNF therapy","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.clinthera.2018.04.016_bib83","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.clinthera.2018.04.016_bib84","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","volume":"53","year":"1999","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.clinthera.2018.04.016_bib85","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alphatherapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.clinthera.2018.04.016_bib86","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Mariette","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.clinthera.2018.04.016_bib87","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/art.24941","article-title":"Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?","volume":"60","author":"Askling","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.clinthera.2018.04.016_bib88","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-138-10-200305200-00008","article-title":"Case reports of heart failure after therapy with a tumor necrosis factor antagonist","volume":"138","author":"Kwon","year":"2003","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.clinthera.2018.04.016_bib89","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","article-title":"Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases","volume":"306","author":"Grijalva","year":"2011","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.clinthera.2018.04.016_bib90","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib91","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI110127","article-title":"Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis","volume":"67","author":"Alspaugh","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2018.04.016_bib92","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI110083","article-title":"Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis","volume":"67","author":"Ferrell","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2018.04.016_bib93","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13075-017-1423-9","article-title":"Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology","volume":"19","author":"Sherina","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2018.04.016_bib94","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.3800119","article-title":"Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization","volume":"17","author":"Mehraein","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib95","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/rheumatology\/kex469","article-title":"Recurrent serious infections in patients with rheumatoid arthritis\u2014results from the British Society for Rheumatology Biologics Register","volume":"57","author":"Subesinghe","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2018.04.016_bib96","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/art.1780140119","article-title":"Infection in rheumatoid arthritis","volume":"14","author":"Baum","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib97","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/anr.1780320422","article-title":"Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders","volume":"32","author":"Goldenberg","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib98","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM195310012491402","article-title":"Length of life and cause of death in rheumatoid arthritis","volume":"249","author":"Cobb","year":"1953","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.04.016_bib99","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.1780130204","article-title":"Survivorship and death in rheumatoid arthritis","volume":"13","author":"Uddin","year":"1970","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.04.016_bib101","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.clinthera.2018.04.016_bib102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1479-5876-12-77","article-title":"Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-alpha antagonists","volume":"12","author":"Germano","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.clinthera.2018.04.016_bib103","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2018.04.016_bib104","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.04.016_bib105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/ard.2005.044404","article-title":"Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study","volume":"65","author":"Weinblatt","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2018.04.016_bib106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/BOR.0000000000000389","article-title":"Infections in rheumatoid arthritis","volume":"29","author":"Atzeni","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib107","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar3542","article-title":"Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor","volume":"13","author":"Kobie","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2018.04.016_bib108","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/rheumatology\/kes202","article-title":"TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients","volume":"51","author":"Franca","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2018.04.016_bib109","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","article-title":"The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination","volume":"67","author":"Gelinck","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2018.04.016_bib110","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2018.04.016_bib111","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar4427","article-title":"Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis","volume":"16","author":"Kapetanovic","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2018.04.016_bib112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2018.04.016_bib113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00124743-199604000-00001","article-title":"Pneumococcal vaccine in rheumatoid arthritis","volume":"2","author":"O'Dell","year":"1996","journal-title":"J Clin Rheumatol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818301589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818301589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:53:01Z","timestamp":1693684381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818301589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0149291818301589"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.04.016","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti\u2013TNF-\u03b1 Agents on B Lymphocytes: A Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}